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Mutation Analysis of the PVRL1 Gene in Caucasians
with Nonsyndromic Cleft Lip/Palate
Mehmet A. So¨zen,1,2 Jacqueline T. Hecht,3 and Richard A. Spritz2
Nonsyndromic cleft lip with or without cleft palate (nsCL=P, MIM 119530) is perhaps the most common major
birth defect. Homozygous PVRL1 loss-of-function mutations result in an autosomal recessive CL=P syndrome,
CLPED1, and a PVRL1 nonsense mutation is associated with sporadic nsCL=P in Northern Venezuela. To address
the more general role of PVRL1 variation in risk of nsCL=P, we carried out mutation analysis of PVRL1 in North
American and Australian nsCL=P cases and population-matched controls. We identified a total of 15 variants, 5 of
which were seen in both populations and 1 of which, an in-frame insertion at Glu442, was more frequent in
patients than in controls in both populations, though the difference was not statistically significant. Another
variant, which is specific to the PVRL1 b (HIgR) isoform, S447L, was marginally associated with nsCL=P in North
American Caucasian patients, but not in Australian patients, and overall variants that affect the b-isoform were
significantly more frequent among North American patients. One Australian patient had a splice junction mu-
tation of PVRL1. Our results suggest that PVRL1 may play a minor role in susceptibility to the occurrence of
nsCL=P in some Caucasian populations, and that variation involving the b (HIgR) isoform might have particular
importance for risk of orofacial clefts. Nevertheless, these results underscore the need for studies that involve very
large numbers when assessing the possible role of rare variants in risk of complex traits such as nsCL=P.
Introduction
Cleft lip with orwithout cleft palate (CL=P) is one ofthe most common birth defects, occurring in approxi-
mately 1 per 800North American Caucasian infants (Tolarova
and Cervenka, 1998), and also with high frequency in other
populations around the world. Approximately two-thirds of
CL=P cases occur as an isolated, sporadic birth defect. Such
nonsyndromic CL=P (nsCL=P) appears to be a multifactorial,
polygenic disorder, each locus exerting a relatively modest
effect against a complex outbred background (Mitchell and
Risch, 1992; Mitchell, 1997).
Many candidate genes for nsCL=P have been assessed,with
varying degrees of support for a large number (Schutte and
Murray, 1999; Bender, 2000; Spritz, 2001; Cobourne, 2004;
Stanier and Moore, 2004). Several lines of evidence support a
possible role in nsCL=P for one or more genes of the nectin
family, which encode a group of cell adhesion molecules.
Homozygous loss-of-function mutations in the gene encoding
nectin-1, PVRL1, result in a rare autosomal recessive CL=P
syndrome, termed CLPED1 (Suzuki et al., 2000). A heterozy-
gous nonsense mutation of PVRL1 has been associated with
sporadic nsCL=P in Northern Venezuela (Sozen et al., 2001).
Several subsequent studies have supported (Turhani et al.,
2005; Avila et al., 2006; Neiswanger et al., 2006; Scapoli
et al., 2006) or not supported (Scapoli et al., 2004; Ichikawa et al.,
2006; Tseng et al., 2006) a role for PVRL1 in risk of nsCL=P.
Two other genes of the nectin family, PVR and PVRL2, have
also been considered as possible candidate genes for nsCL=P
(Neiswanger et al., 2006; Warrington et al., 2006; Pezzetti et al.,
2007), due to their paralogy with PVRL1 and their loca-
tion in chromosome segment 19q13.2, which corresponds to
a linkage region for nsCL=P, OFC3 (MIM 600757; Stein
et al., 1995).
PVRL1 encodes three distinct proteins (Lopez et al., 2001),
the result of alternative RNA splicing, each sharing an amino-
terminal segment, consisting of three immunoglobulin do-
mains, but with three completely different carboxyl-terminal
segments encoded by different exons (Suzuki et al., 2000)
(Fig. 1). The PVRL1 a-isoform encodes nectin-1 (PRR1), the
cell-surface transmembrane receptor of a cell–cell adhesion
system (Takahashi et al., 1999). The PVRL1 g-isoform encodes
a truncated PVRL1 protein that may regulate nectin-mediated
cell adhesion by competitive inhibition (Lopez et al., 2001).
The PVRL1 b-isoform encodes HIgR, an apparent transmem-
brane receptor with a carboxyl segment entirely different
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from nectin-1 and whose specific function is unknown. As
shown in Figure 1, the PVRL1 b-isoform is encoded by exons
1–8, the PVRL1 a-isoform by exons 1–5 and exon 6A, and the
PVRL1 g-isoform by exons 1–5 and exon 6G.
The aim of this study was to investigate possible in-
volvement of the PVRL1 gene in risk of nsCL=P in Caucasian
populations. We carried out mutation analysis of both
nsCL=P patients and population-matched controls, screening
all coding exons of the PVRL1 gene encompassing all three
PVRL1 gene isoforms, so as to determine whether variants of
PVRL1 or any specific isoform may contribute to risk of
nsCL=P in Caucasians.
FIG. 1. Schematic genomic organization of PVRL1, and alternative RNA splicing to generate PVRL1 a-, b-, and g-mRNA
isoforms.
Table 1. PVRL1 Polymerase Chain Reaction Primers
Amplicon Primer sequence Isoform
Exon 1F 50-CTG GTTTCTGCTGCGCGAGGA-30 All
Exon 1R 50-AGCAGAGGTGAGCGCCTCTTA-30 All
Exon 2Fa 50-CAGAGCACAGGAACTGTGTGGGT-30 All
Exon 2R Suzuki et al. (2000) All
Exon 3F Suzuki et al. (2000) All
Exon 3R Suzuki et al. (2000) All
Exon 4F Suzuki et al. (2000) All
Exon 4R Suzuki et al. (2000) All
Exon 5F Suzuki et al. (2000) All
Exon 5R Suzuki et al. (2000) All
Exon 6 gamma F 50-AGCCCAAAGCCATAGTGC-30 g
Exon 6 gamma R 50-CAGCTGTCTGACATCAAGC-30 g
Exon 6 gamma R2 50-GTCCCAGGTGAAGTCTCTC-30 g
Exon 6A F Suzuki et al. (2000) a (PRR1)
Exon 6A R Suzuki et al. (2000) a (PRR1)
Exon 6A F 1. half Suzuki et al. (2000) a (PRR1)
Exon 6A R2 1. half 50-GTCCTCGTCATATTTGGGGT-30 a (PRR1)
Exon 6A F 2 2. half 50-TCAGACGACGAGAAGAAGGC-30 a (PRR1)
Exon 6A R 2. half Suzuki et al. (2000) a (PRR1)
Exon 6b F3 50-CAGGGTCTGACTCTCTCACA-30 b (HIgR)
Exon 6b R2 50-ACCAGTGGGAGTTTAGTGGGCA-30 b (HIgR)
Exon 6b R3 50-CTGAGCTTTCACAAGTTTAG-30 b (HIgR)
Exon 7b F Suzuki et al. (2000) b (HIgR)
Exon 7b R Suzuki et al. (2000) b (HIgR)
Exon 8b F Suzuki et al. (2000) b (HIgR)
Exon 8b R Suzuki et al. (2000) b (HIgR)
Exon 8b F2 50-GAAAGGTCTGTGCAGCACTC-30 b (HIgR)
Exon 8b R2 50-CTAAGGCAGCTGGGCTCAT-30 b (HIgR)
Exon 8b F3 50-ATGGAAAGGTCTGTGCAGCA-30 b (HIgR)
Exon 8b R3 50-CTCTAAGGCAGCTGGGCTCA-30 b (HIgR)
aSlightly modified from Suzuki et al. (2000).
F, forward primer; R, reverse primer.
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Materials and Methods
Mutation screening, genotyping, and statistics
Genomic DNA samples were obtained with informed
consent from patients with nsCL=P and controls from differ-
ent populations in North America. We analyzed DNA sam-
ples from 104 nsCL=P patients and 105 controls from North
America, including 44 from Texas, 20 fromMaryland, 20 from
Ohio, and 20 from Iowa, as well 112 nsCL=P patients and 118
controls from Australia. DNA was isolated from bloodspots
(Polski et al., 1998) and used as template for polymerase chain
reaction (PCR), using primers for amplicons spanning the 10
PVRL1 exons described previously (Suzuki et al., 2000), as
well as additional primers specified in Table 1. We screened
amplicons spanning the 10 PVRL1 exons, and adjacent in-
tron and noncoding sequences, by simultaneous single-
strand conformation polymorphism (SSCP)=heteroduplex
analysis for the North American samples, and by denaturing
high-performance liquid chromatography (dHPLC) for the
Australian samples. Variants were defined by purifying the
amplified products by electrophoresis in 0.5MDE gels
(Biowhittaker Molecular Applications, Rockland, ME) con-
taining 10% glycerol (Lee et al., 1995) and sequencing PCR
products showing novel aberrant SSCP=heteroduplex pat-
terns. Allele frequencies were analyzed using Fisher’s exact
test, one-tailed.
Results
We carried out a case–control survey of PVRL1 variants
among 104 unrelated Caucasian nsCL=P patients from North
America versus 105 unrelated North American Caucasian
controls, and 112 unrelated Australian Caucasian nsCL=P
patients versus 118 unrelated Australian Caucasian controls.
We screened the 10 exons of the PVRL1 gene, and adjacent
intron and noncoding sequences, by simultaneous SSCP=
heteroduplex or dHPLC analysis, followed by DNA se-
quencing of PCR products that contained apparent variants.
Table 2. PVRL1 Variants in North American Caucasian Nonsyndromic Cleft Lip Patients




Allele frequency among nsCL=P
patients (n¼ 104)
Allele frequency among
controls (n¼ 105) p-Valuea
V89M (GTG>ATG) 2 a,b,g 2=208 (0.010) 0 ns
R199Q (CGG>CAG) 3 a,b,g 0 2=210 (0.010) ns
442insE (insGAG) 6A a only 22=208 (0.106) 16=210 (0.080) ns
442insEE (insGAGGAG) 6A a only 1=208 (0.005) 2=210 (0.010) ns
G507E (GGG>GAG) 6A a only 0 1=210 (0.005) ns
G361V (GGT>GTT) 6 b only 20=208 (0.096) 13=210 (0.062) ns
P393P (CCG>CCA) 7 b only 7=208 (0.034) 2=210 (0.010) ns
S447L (TCG>CCT) 8 b only 7=208 (0.034) 1=210 (0.005) 0.033
Total affecting a (PRR) isoform 25 21 ns
Total affecting b (HIgR) isoform 36 18 0.006
Total affecting g isoform 2 2 ns
aFisher’s exact test, one-tailed.
ns, nonsignificant; nsCL=P, nonsyndromic cleft lip with or without cleft palate.
Table 3. PVRL1 Variants in Australian Caucasian Nonsyndromic Cleft Lip Patients




Allele frequency among nsCL=P
patients (n¼ 112)
Allele frequency among
controls (n¼ 118) p-Valuea
V28I (GTC>ATC) 2 a,b,g 0 1=230 (0.005) ns
L114L (CTG>CTA) 2 a,b,g 0 1=230 (0.005) ns
E125E (GAG>GAA) 2 a,b,g 0 1=230 (0.005) ns
T187T (ACT>ACA) 3 a,b,g 1=220 (0.005) 0 ns
R199Q (CGG>CAG) 3 a,b,g 4=216 (0.019) 3=230 (0.013) ns
T206T (ACG>ACA) 3 a,b,g 1=220 (0.005) 1=230 (0.005) ns
IVS4þ 1G>A 4 a,b,g 1=220 (0.005) 0 ns
442insE (insGAG) 6A a only 30=220 (0.136) 23=230 (0.100) ns
442insEE (insGAGGAG) 6A a only 0 1=230 (0.005) ns
E335D (GAA>GAC) 6 b only 20=220 (0.091) 19=236 (0.081) ns
G361V (GGT>GTT) 6 b only 0 1=234 (0.005) ns
P393P (CCG>CCA) 7 b only 1=222 (0.005) 0 ns
Total affecting a (PRR1) isoform 37 31 ns
Total affecting b (HIgR) isoform 28 28 ns
Total affecting g isoform 7 7 ns
aFisher’s exact test, 1-tailed.
ns, nonsignificant; nsCL=P, nonsyndromic cleft lip with or without cleft palate.
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As shown in Table 2, among North American Caucasian
nsCL=P patients and controls we identified a total of eight
variants, two of which, 442insE and G361V, were relatively
common and slightly more frequent in patients than in con-
trols. Two variants affect all three PVRL1 isoforms, three af-
fect only the a (PRR1) isoform, and three affect only the b
(HIgR) isoform. When we considered each variant individu-
ally, only one, S447L, was significantly more prevalent among
cases than among controls ( p¼ 0.033). When we considered
all variants affecting each isoform together, while there was
no significant difference between nsCL=P cases and controls
for variants affecting the a (PRR1) isoform or g-isoform vari-
ants affecting the b (HIgR) isoform were significantly more
frequent in nsCL=P cases than in controls ( p¼ 0.006).
However, this finding was not replicated in Australian
cases and controls, in whom we identified a total of 12 vari-
ants, of which 442insE and G361V again were relatively
common. As shown in Table 3, no individual variant occurred
significantly more frequently among cases than among con-
trols. Further, when we considered variants affecting each
isoform together, we likewise found no significant difference.
Nevertheless, in one Australian nsCL=P patient we observed
a splice junction mutation, IVS4þ 1G>A, that constitutes a
clear loss-of-function mutation that would abolish expression
of all three PVRL1 mRNA isoforms from this allele.
Analysis of rare variants in a complex disease is problem-
atic. In any given study, the observed frequencies of any
specific variant may be too low to permit reliable conclusions
to be drawn. This problem is compounded if the gene in
question contributes only a small fraction of total liability. In
the present study, we observed a higher frequency of the
PVRL1 b (HIgR) isoform-specific variant, S447L, in North
American nsCL=P cases than in North American controls, as
well as a higher frequency of variants affecting the b-isoform
overall. However, we did not observe the S447L variant
among Australians at all, either in cases or in controls, sug-
gesting that these two populations may not be strictly com-
parable. Moreover, in the course of this study we found one
splice junction mutation (IVS4þ 1G>A) in an Australian
nsCL=P patient. While this variant is of obvious functional
significance, and would abolish expression of all three PVRL1
isoforms from the variant allele, the general frequency of
obviously deleterious alleles of PVRL1 in different popula-
tions is not yet known. It is clear that sequence analyses of
far larger numbers of cases and controls will be necessary to
assess the relevance of rare PVRL1 variants to the pathogen-
esis of nsCL=P.
Discussion
PVRL1 is expressed in the developing palatal epithelium,
tooth buds, and skin keratinocytes, consistent with the phe-
notype of patients with CLPED1 syndrome who completely
lack all three isoforms because of null-mutant alleles (Suzuki
et al., 2001). The slightly increased frequency of PVRL1 vari-
ants that affect the b- (HIgR) and a-isoforms in patients with
sporadic, nsCL=P suggests that the b-isoform might be spe-
cifically involved in craniofacial development. The g-isoform
may thus relate more to the skin-hair, tooth, and hand aspects
of the CLPED1 syndromic phenotype. It will thus be of in-
terest to assess the developmental expression of each of the
three PVRL1 isoforms individually. Further, whereas the
PVRL1 a (PRR1) isoform is a cell–cell adhesion molecule that
interfaces with afadin via its intracellular carboxyl domain
(Takahashi et al., 1999), the intracellular carboxyl domain of
the b (HIgR) isoform is entirely different, suggesting that its
function likewise is entirely different. It thus will be of great
importance to determine the function and biology of the
PVRL1 HIgR isoform and clarify its role in craniofacial de-
velopment.
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